Catherine Crofts1, Grant Schofield2, Caryn Zinn2, Mark Wheldon3, Joseph Kraft4. 1. Human Potential Centre, AUT University, Auckland, New Zealand. Electronic address: ccrofts@aut.ac.nz. 2. Human Potential Centre, AUT University, Auckland, New Zealand. 3. Department of Biostatistics and Epidemiology, AUT University, Auckland, New Zealand. 4. Department of Clinical Pathology and Nuclear Medicine, St Joseph Hospital, Chicago, IL, USA.
Abstract
OBJECTIVE: Hyperinsulinaemia is associated with development of chronic metabolic disease and is emerging as a health risk independent to that of insulin resistance. However, little is known to what extent hyperinsulinaemia occurs with normal glucose tolerance in lean subjects. METHOD: Oral glucose tolerance tests with concurrent insulin assay were conducted during the 1970s-1990s. Participants were classified according to glucose tolerance and insulin response pattern. Analysis of variance compared differences in plasma glucose, plasma insulin, and demographic and metabolic risk factors between groups. RESULTS: Participants with normal glucose tolerance comprised 54% (n=4185) of the total cohort. Of these, just over half (n=2079) showed hyperinsulinaemia despite normal glucose clearance. Obesity had a modest association with hyperinsulinaemia in people with normal glucose tolerance. Fasting insulin had limited value in diagnosing hyperinsulinaemia. The majority of participants (93%) with impaired glucose tolerance or diabetes had concurrent hyperinsulinaemia. CONCLUSION: Hyperinsulinaemia in the absence of impaired glucose tolerance may provide the earliest detection for metabolic disease risk and likely occurs in a substantial proportion of an otherwise healthy population. Dynamic insulin patterning may produce more meaningful and potentially helpful diagnoses. Further research is needed to investigate clinically useful hyperinsulinaemia screening tools.
OBJECTIVE:Hyperinsulinaemia is associated with development of chronic metabolic disease and is emerging as a health risk independent to that of insulin resistance. However, little is known to what extent hyperinsulinaemia occurs with normal glucose tolerance in lean subjects. METHOD: Oral glucose tolerance tests with concurrent insulin assay were conducted during the 1970s-1990s. Participants were classified according to glucose tolerance and insulin response pattern. Analysis of variance compared differences in plasma glucose, plasma insulin, and demographic and metabolic risk factors between groups. RESULTS:Participants with normal glucose tolerance comprised 54% (n=4185) of the total cohort. Of these, just over half (n=2079) showed hyperinsulinaemia despite normal glucose clearance. Obesity had a modest association with hyperinsulinaemia in people with normal glucose tolerance. Fasting insulin had limited value in diagnosing hyperinsulinaemia. The majority of participants (93%) with impaired glucose tolerance or diabetes had concurrent hyperinsulinaemia. CONCLUSION:Hyperinsulinaemia in the absence of impaired glucose tolerance may provide the earliest detection for metabolic disease risk and likely occurs in a substantial proportion of an otherwise healthy population. Dynamic insulin patterning may produce more meaningful and potentially helpful diagnoses. Further research is needed to investigate clinically useful hyperinsulinaemia screening tools.
Authors: Susan J Burke; Heidi M Batdorf; David H Burk; Robert C Noland; Adrianna E Eder; Matthew S Boulos; Michael D Karlstad; J. Jason Collier Journal: J Diabetes Res Date: 2017-09-06 Impact factor: 4.011
Authors: Isabella D Cooper; Catherine A P Crofts; James J DiNicolantonio; Aseem Malhotra; Bradley Elliott; Yvoni Kyriakidou; Kenneth H Brookler Journal: Open Heart Date: 2020-09